SARTORIUS STED BIO (EPA:DIM) | Finanzwire

Basculer en Français

10562	Companies
223400	Keywords
152426	Articles
118218	Press releases

Home
Companies
SARTORIUS STED BIO

BRIEF

published on 07/22/2025 at 07:07, 10 months 21 days ago

Sartorius Stedim Biotech Releases H1 2025 Financial Report

Business Development Biopharmaceutical Industry Half-year Results Sartorius Stedim 2025 Financial Report
BRIEF

published on 07/22/2025 at 07:05, 10 months 21 days ago

Sartorius Stedim Biotech Reports Solid Half-Year 2025 Results

Profitability Sales Growth Sartorius Stedim Biotech Biopharmaceutical Industry Half-year Results 2025
PRESS RELEASE

published on 07/22/2025 at 07:02, 10 months 21 days ago

Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA releases first half 2025 results and full year forecast. Report available online with financial statements and company profile

Financial Statements Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry First Half 2025 Results
PRESS RELEASE

published on 07/22/2025 at 07:00, 10 months 21 days ago

Half-year results 2025 of Sartorius Stedim Biotech
Sartorius Stedim Biotech reports strong half-year results for 2025 with sales revenue up 9.4% in constant currencies and underlying EBITDA rising by 19.3%

Sartorius Stedim Biotech Sales Revenue Half-year Results 2025 Underlying EBITDA
BRIEF

published on 07/03/2025 at 10:04, 11 months 9 days ago

Sartorius Stedim Biotech SA: Share and Voting Rights Declaration

Voting Rights Shares Issued Capital Regulatory News Sartorius Stedim
BRIEF

published on 07/03/2025 at 10:03, 11 months 9 days ago

Sartorius Stedim Biotech Half-Year Liquidity Contract Update

Liquidity Shares Market Practice Buy-Sell Trade Volume
PRESS RELEASE

published on 07/03/2025 at 09:59, 11 months 9 days ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares the number of shares and voting rights comprising the issued capital per regulatory requirements

Voting Rights Capital Shares Sartorius Stedim Biotech SA Regulatory Requirements
PRESS RELEASE

published on 07/03/2025 at 09:58, 11 months 9 days ago

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA releases half-year liquidity contract statement. Details include shares, amount, and trading volumes

Liquidity Contract Shares Kepler Cheuvreux Sartorius Stedim Biotech Trading Volumes
BRIEF

published on 06/18/2025 at 21:38, 11 months 23 days ago

Michael Grosse takes over as Chairman of the Board of Directors of Sartorius Stedim Biotech SA

Board Of Directors Sartorius Stedim Biotech Biopharmaceuticals Joachim Kreuzburg Michael Grosse
PRESS RELEASE

published on 06/18/2025 at 21:33, 11 months 23 days ago

Sartorius Stedim Biotech SA: Incoming Sartorius CEO Michael Grosse to become Chairman of the Board of Sartorius Stedim Biotech S.A.
Michael Grosse appointed Chairman of the Board of Sartorius Stedim Biotech S.A. as Dr. Kreuzburg resigns. Learn about the new CEO's rich industry experience

Chairman Sartorius Stedim Biotech CEO Board Michael Grosse

Accesswire

Published on 06/12/2026 at 15:14, 2 hours 45 minutes ago

Reeflex Solutions Inc. Reports Voting Results From Annual and Special Meeting of Shareholders
Published on 06/12/2026 at 15:00, 2 hours 59 minutes ago

Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
Published on 06/12/2026 at 14:00, 3 hours 59 minutes ago

Revolve Closes Acquisition of Three-Project, 125 MW US Development-Stage Solar Portfolio
Published on 06/12/2026 at 13:30, 4 hours 29 minutes ago

Nextech3D.ai to Host Livestream Shareholder Update on Q4 Results, Audited FY2026 Financials, and AI Platform Growth Outlook
Published on 06/12/2026 at 13:30, 4 hours 29 minutes ago

Algo Grande Copper Commences Phase II Drill Program at Adelita Project

View all ACCESSWIRE

EQS Group

Published on 06/12/2026 at 17:45, 14 minutes ago

Interroll Annual General Meeting 2026: Shareholders approve all proposals
Published on 06/12/2026 at 17:05, 54 minutes ago

H&K AG: Heckler & Koch successfully completes refinancing
Published on 06/12/2026 at 17:05, 54 minutes ago

EQS-Adhoc: H&K AG: Heckler & Koch successfully completes refinancing
Published on 06/12/2026 at 16:38, 1 hour 21 minutes ago

Cherry SE announces a cash capital increase with subscription rights offering to strengthen its financial position and support the implementation of its future-oriented program, “Project Blossom”
Published on 06/12/2026 at 16:21, 1 hour 38 minutes ago

CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Delisting Completed and Squeeze Out Initiated

Les Echos

Published on 06/12/2026 at 10:34, 7 hours 25 minutes ago

CHANGE IN THE SHARE CAPITAL
Published on 06/12/2026 at 09:00, 8 hours 59 minutes ago

Pricing of Green Senior Secured Notes due 2031 by Neoen FINCO PLC
Published on 06/11/2026 at 20:30, 21 hours 29 minutes ago

Mersen joins the SBF 120 index
Published on 06/11/2026 at 17:45, 1 day ago

BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026
Published on 06/11/2026 at 08:45, 1 day 9 hours ago

Air Liquide and ArianeGroup renew strategic industrial partnership with two major Ariane 6 contracts

View all LES ECHOS COMFI WIRE